The Pharma 5 Research and Development Department, with significant dedicated human and material resources, is completely independent from the other activities.
With state-of-the-art technology and high-performance supervision, this department enables Pharma 5 to consolidate its leading position and outline the company’s development prospects.
More than 95% of the medicines manufactured by the Group are designed and developed within its own Research and Development Department, under the highest quality standards (GMP1 standards, GLP2, WHO3, ICH4 et EDQM5).
Our independent mastery of this strategic know-how made us stand out by meeting patients’ needs actively, efficiently and safely – in particular, with regards to Public Health issues. For instance, we have developed antituberculous drugs for which we have international patents.
1. GMP : Good Manufacturing Practices
1. GLP : Good Laboratory Practices
2. WHO : World Health Organization
3.ICH : International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human use
4. EDQM : European Directorate for the Quality of Medicines